Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹2760 Cr | ₹7404 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 14 Jul 1999 | 01 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 32% | 21% |
| Expense Ratio | 2 | 1.82 |
| Manager | Pradeep Kesavan | Sailesh Raj Bhan |
| ISIN Code | INF200K01446 | INF204K01968 |
| Exits Load | Exit load of 0.50% if redeemed within 15 days/365 | Exit load of 1% if redeemed within 1 month./365 |
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | -0.1% | -2.35% |
| 6 Month | 19.86% | 15.63% |
| 1 Year | 44.15% | 35.72% |
| 3 Year | 23.36% | 18.76% |
| 5 Year | 28.61% | 27.41% |
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 44.48% | 31.44% |
| 3 Year | 35.88% | 30.78% |
| 5 Year | 28.53% | 25.57% |
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 14.51% | 17.79% |
| 3 Year | 17.07% | 20.87% |
| 5 Year | 12.42% | 20.18% |
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | 14.02% | 14.36% |
| Sharp | 0.78% | 0.68% |
| Beta | 0.87% | 0.91% |
| Alpha | 3.06% | 1.57% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Pradeep Kesavan | Sailesh Raj Bhan |
| Total AUM | ₹434274 Cr | ₹96086 Cr |
| Fund Manage | 43 | 5 |
| SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 8.5 | 4.4 |
| Small Cap | 36.36 | 22.52 |
| Mid Cap | 25.23 | 27.12 |
| Large Cap | 29.91 | 45.96 |
| Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 8.5 | 4.4 |
| Pharmaceuticals & Biotechnology | 58.42 | 75.86 |
| Healthcare Services | 24.75 | 17.38 |
| Chemicals & Petrochemicals | 3.9 | - |
| Healthcare Equipment & Supplies | 4.43 | - |
| Retailing | - | 2.36 |
Top Comparisons
Aditya Birla Sun Life Balanced Advantage Fund - Regular Plan - Growth Option
3Y Returns10.68%
360 ONE Balanced Hybrid Fund Regular - Growth
3Y Returns0%
Aditya Birla Sun Life Global Emerging Opportunities Fund - Regular Plan - Growth Option
3Y Returns4.98%
Sundaram Global Brand Fund Regular Plan - Growth
3Y Returns6.03%
Tata Mid Cap Growth Fund Regular Plan- Growth Option
3Y Returns18.65%
HSBC Midcap Fund - Regular Growth
3Y Returns21.72%
HDFC Credit Risk Debt Fund - Growth Option
3Y Returns6.08%
Axis Credit Risk Fund - Regular Plan - Growth
3Y Returns6.2%